|
Women with
a genetic predisposition to breast or ovarian cancer do not carry
the same increased risk of colorectal cancer, according to two
studies reported in the Journal of the National Cancer Institute.
Mutations
in BRCA1 and BRCA2 genes, which are present in about 2.5 percent
of the Ashkenazi Jewish population, have been linked to an increased
risk of breast and ovarian cancer, and some earlier studies have
suggested an increased risk of colorectal cancer as well..
But in one
study, researchers compared the incidence of BRCA1/2 mutations
in 586 Ashkenazi Jewish patients with colorectal cancer with that
of 5,012 patients with no known history of colorectal cancer,
and found no association between the presence of a BRCA mutation
and risk of colorectal cancer.
In the second
study, University of Michigan researchers performed genetic testing
on 1,422 patients with colorectal cancer and 1,566 control subjects
without colorectal cancer in Israel, and also found no link.
"We found
no strong common genetic basis between colorectal and breast cancer,"
said Dr. Stephen B. Gruber of the University of Michigan's Comprehensive
Cancer Center. "They are different diseases with different
genetic factors."
Other
Sources: Journal of the National Cancer Institute
|